PLAT and hematocrit: Our findings indicate that HMGB1-mediated inflammation and BBB breakdown may contribute to tPA-induced occurrence of HT and death in ischemic stroke, and that blocking HMGB1 signaling would be helpful to prevent the complications brought by thrombolysis.